🇺🇸 FDA
Patent

US 7855076

Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

granted A61KA61K2039/505A61K2039/5154

Quick answer

US patent 7855076 (Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/505, A61K2039/5154, A61K39/001102